Responses
Poster Presentations
SLE, Sjögren's and APS - treatment
SAT0243 Exposure-response (E-R) analysis for selection of optimal dosage regimen of anifrolumab in patients (PTS) with systemic lupus erythematosus (SLE)
Compose a Response to This Article
Other responses
No responses have been published for this article.